Edesa Biotech, Inc.

EDSA

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001171843-26-001329
Filing date: Mar 4, 2026
Earliest execution date: Mar 3, 2026
Reporting Owners: Nijhawan Pardeep (CEO)

Summary

Type

Buy

Net shares

+10,000

% of shares

0.89%

Amount (USD)

$36,300

Insider confidence score

68.8 out of 100

Positive

  • Significant buy (≥0.5% of shares)

Negative

  • Small buy amount (<$50K)

Stock transactions

Transaction 1

Security

Common Shares

Action

Buy

Date

2026-03-03

Code

P

Net shares

+10,000.0

Price per Share

$3.63

Amount (USD)

$36,300.00

Acquired/Disposed

Acquired

Shares Owned Before

372,702.0

Shares Owned After

382,702.0

Filing's footnotes

1. Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

2. Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.